J DRUG TARGET 润色咨询

JOURNAL OF DRUG TARGETING

出版年份：1993 年文章数：1206 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：2.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=514587, encodeId=ce7151458ec7, content=亲们，最近有人投过这个杂志吗？经历的状态是什么个过程？谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue Aug 18 08:57:00 CST 2015, time=2015-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503650, encodeId=143c5036504e, content=审稿速度:2.0<br>经验分享：做了个3-MA抑制PI3K pathway的，审稿<2个月，修改1周投回，<20天后被接收。审稿人说我的实验设计合理，用实验论证充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sokuren, createdTime=Thu Jun 19 12:59:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499905, encodeId=ed98499905c7, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：第一次投稿，没被拒。非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 19 19:25:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492417, encodeId=7d0549241e3e, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484548, encodeId=6f41484548d3, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：新药筛选,靶点方面文章容易发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 23:36:00 CST 2011, time=2011-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484541, encodeId=0981484541ed, content=为什么不把提高平台给作者啊！！！ 厚道些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 17:15:00 CST 2011, time=2011-09-22, status=1, ipAttribution=)]
    2015-08-18 lao6

    亲们，最近有人投过这个杂志吗？经历的状态是什么个过程？谢谢~

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=514587, encodeId=ce7151458ec7, content=亲们，最近有人投过这个杂志吗？经历的状态是什么个过程？谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue Aug 18 08:57:00 CST 2015, time=2015-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503650, encodeId=143c5036504e, content=审稿速度:2.0<br>经验分享：做了个3-MA抑制PI3K pathway的，审稿<2个月，修改1周投回，<20天后被接收。审稿人说我的实验设计合理，用实验论证充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sokuren, createdTime=Thu Jun 19 12:59:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499905, encodeId=ed98499905c7, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：第一次投稿，没被拒。非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 19 19:25:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492417, encodeId=7d0549241e3e, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484548, encodeId=6f41484548d3, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：新药筛选,靶点方面文章容易发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 23:36:00 CST 2011, time=2011-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484541, encodeId=0981484541ed, content=为什么不把提高平台给作者啊！！！ 厚道些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 17:15:00 CST 2011, time=2011-09-22, status=1, ipAttribution=)]
    2014-06-19 sokuren

    审稿速度:2.0
    经验分享：做了个3-MA抑制PI3K pathway的，审稿<2个月，修改1周投回，<20天后被接收。审稿人说我的实验设计合理，用实验论证充分。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=514587, encodeId=ce7151458ec7, content=亲们，最近有人投过这个杂志吗？经历的状态是什么个过程？谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue Aug 18 08:57:00 CST 2015, time=2015-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503650, encodeId=143c5036504e, content=审稿速度:2.0<br>经验分享：做了个3-MA抑制PI3K pathway的，审稿<2个月，修改1周投回，<20天后被接收。审稿人说我的实验设计合理，用实验论证充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sokuren, createdTime=Thu Jun 19 12:59:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499905, encodeId=ed98499905c7, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：第一次投稿，没被拒。非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 19 19:25:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492417, encodeId=7d0549241e3e, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484548, encodeId=6f41484548d3, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：新药筛选,靶点方面文章容易发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 23:36:00 CST 2011, time=2011-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484541, encodeId=0981484541ed, content=为什么不把提高平台给作者啊！！！ 厚道些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 17:15:00 CST 2011, time=2011-09-22, status=1, ipAttribution=)]
    2013-11-19 匿名用户

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享：第一次投稿，没被拒。非常感谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=514587, encodeId=ce7151458ec7, content=亲们，最近有人投过这个杂志吗？经历的状态是什么个过程？谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue Aug 18 08:57:00 CST 2015, time=2015-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503650, encodeId=143c5036504e, content=审稿速度:2.0<br>经验分享：做了个3-MA抑制PI3K pathway的，审稿<2个月，修改1周投回，<20天后被接收。审稿人说我的实验设计合理，用实验论证充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sokuren, createdTime=Thu Jun 19 12:59:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499905, encodeId=ed98499905c7, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：第一次投稿，没被拒。非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 19 19:25:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492417, encodeId=7d0549241e3e, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484548, encodeId=6f41484548d3, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：新药筛选,靶点方面文章容易发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 23:36:00 CST 2011, time=2011-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484541, encodeId=0981484541ed, content=为什么不把提高平台给作者啊！！！ 厚道些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 17:15:00 CST 2011, time=2011-09-22, status=1, ipAttribution=)]
    2012-11-28 qupeter

    明年能不能冲到3分？大家谈谈

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=514587, encodeId=ce7151458ec7, content=亲们，最近有人投过这个杂志吗？经历的状态是什么个过程？谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue Aug 18 08:57:00 CST 2015, time=2015-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503650, encodeId=143c5036504e, content=审稿速度:2.0<br>经验分享：做了个3-MA抑制PI3K pathway的，审稿<2个月，修改1周投回，<20天后被接收。审稿人说我的实验设计合理，用实验论证充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sokuren, createdTime=Thu Jun 19 12:59:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499905, encodeId=ed98499905c7, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：第一次投稿，没被拒。非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 19 19:25:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492417, encodeId=7d0549241e3e, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484548, encodeId=6f41484548d3, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：新药筛选,靶点方面文章容易发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 23:36:00 CST 2011, time=2011-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484541, encodeId=0981484541ed, content=为什么不把提高平台给作者啊！！！ 厚道些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 17:15:00 CST 2011, time=2011-09-22, status=1, ipAttribution=)]
    2011-09-22 匿名用户

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享：新药筛选,靶点方面文章容易发表

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=514587, encodeId=ce7151458ec7, content=亲们，最近有人投过这个杂志吗？经历的状态是什么个过程？谢谢~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue Aug 18 08:57:00 CST 2015, time=2015-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503650, encodeId=143c5036504e, content=审稿速度:2.0<br>经验分享：做了个3-MA抑制PI3K pathway的，审稿<2个月，修改1周投回，<20天后被接收。审稿人说我的实验设计合理，用实验论证充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sokuren, createdTime=Thu Jun 19 12:59:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499905, encodeId=ed98499905c7, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：第一次投稿，没被拒。非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 19 19:25:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492417, encodeId=7d0549241e3e, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484548, encodeId=6f41484548d3, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：新药筛选,靶点方面文章容易发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 23:36:00 CST 2011, time=2011-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484541, encodeId=0981484541ed, content=为什么不把提高平台给作者啊！！！ 厚道些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=427, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Sep 22 17:15:00 CST 2011, time=2011-09-22, status=1, ipAttribution=)]
    2011-09-22 匿名用户

    为什么不把提高平台给作者啊！！！ 厚道些吧

    0

共28条页码: 2/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分